Stay updated on APR-246 & Azacitidine in TP53 MDS Clinical Trial
Sign up to get notified when there's something new on the APR-246 & Azacitidine in TP53 MDS Clinical Trial page.

Latest updates to the APR-246 & Azacitidine in TP53 MDS Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedThe record history adds a new revision entry (v3.4.2) and removes the previous revision (v3.4.1). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoChange DetectedRevision: v3.4.1 was added and Revision: v3.4.0 was removed in the study history; this is a minor metadata update to the record's version history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check41 days agoChange DetectedAdded revision entry v3.3.4 and removed revision v3.3.3 from the study record history, reflecting an update to the page's version history.SummaryDifference0.1%

- Check62 days agoChange DetectedThe history page shows a new revision entry 'Revision: v3.3.3' and removes 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' from the footer.SummaryDifference0.2%

- Check91 days agoChange DetectedThe history now shows a new revision entry v3.3.2 and removes v3.2.0, reflecting an update to the record-keeping. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check99 days agoChange DetectedRemoval of the government funding/operating status banner from the page. No other changes to the study history content are shown.SummaryDifference0.6%

Stay in the know with updates to APR-246 & Azacitidine in TP53 MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the APR-246 & Azacitidine in TP53 MDS Clinical Trial page.